| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $860.9M | +21.8% |
| Cost of Revenue | $482.4M | +18.7% |
| Gross Profit | $378.5M | +26.0% |
| R&D Expense | $85.8M | +18.3% |
| SG&A Expense | $158.9M | +23.0% |
| Operating Income | $103.1M | +60.9% |
| Pre-tax Income | $87.2M | +55.2% |
| Income Tax | $13.1M | +124.4% |
| Net Income | $74.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.1M | -14.7% |
| Accounts Receivable | $137.7M | +19.1% |
| Inventory | $168.0M | +33.7% |
| Current Assets | $420.5M | +12.5% |
| Total Assets | $1.24B | +1.1% |
| Current Liabilities | $164.5M | -10.6% |
| Long-term Debt | $430.7M | +0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.8M | -4.1% |
| Capital Expenditures | $19.6M | -1.7% |
| Investing Cash Flow | -$42.5M | +86.1% |
| Financing Cash Flow | -$60.2M | -129.4% |
| Free Cash Flow | $71.1M | -4.7% |
| +47.1% |
| EPS (Basic) | $2.08 | +46.5% |
| EPS (Diluted) | $2.06 | +46.1% |
| Total Liabilities |
| $663.6M |
| -6.1% |
| Stockholders' Equity | $577.6M | +10.8% |